IP Verse

Silence Therapeutics competitive analysis

Loading summary...

Latest oppositions filed by Silence Therapeutics

Explore patent oppositions filed by Silence Therapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2813582
Rna Interference Mediating Small Rna MoleculesEUROPISCHES LABORATORIUM FR MOLEKULARBIOLOGIE EMBLJan 12, 2018
EP1798285
Methods And Medicament For Inhibition The Expression Of A Defined GeneALNYLAM EUROPEDec 15, 2017

Latest patents of Silence Therapeutics opposed by its competitors

Explore Silence Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3607069
Nov 2, 2022Products And Compositions1
EP1857547
Dec 2, 2020Further Novel Forms Of Interfering Rna Molecules3
EP2258847
Jul 1, 2020Futher Novel Forms Of Interfering Rna Molecules3
EP3222724
Oct 31, 2018Further Novel Forms Of Interfering Rna Molecules1

Latest publications and patents of Silence Therapeutics New

Explore the latest publications and patents granted to Silence Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Silence Therapeutics

EP3607069
Nov 2, 2022Products And CompositionsGranted And Under Opposition
EP1857547
Dec 2, 2020Further Novel Forms Of Interfering Rna MoleculesPatent Maintained As Amended
EP2258847
Jul 1, 2020Futher Novel Forms Of Interfering Rna MoleculesPatent Maintained As Amended
EP3222724
Oct 31, 2018Further Novel Forms Of Interfering Rna MoleculesGranted And Under Opposition

Latest PTAB cases involving Silence Therapeutics

Discover the latest PTAB cases involving Silence Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 24, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Silence Therapeutics

PGR2018-00088Jul 17, 2018ALNYLAM PHARMACEUTICALSSILENCE THERAPEUTICSTerminated-Settled
PGR2018-00089Jul 17, 2018ALNYLAM PHARMACEUTICALSSILENCE THERAPEUTICSTerminated-Settled
PGR2018-00075Jul 9, 2018ALNYLAM PHARMACEUTICALSSILENCE THERAPEUTICSTerminated-Settled
PGR2018-00067Jun 11, 2018ALNYLAM PHARMACEUTICALSSILENCE THERAPEUTICSTerminated-Settled
PGR2018-00059Apr 2, 2018ALNYLAM PHARMACEUTICALSSILENCE THERAPEUTICSTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Silence Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SILENCE THERAPEUTICS28 - 5
ALNYLAM PHARMACEUTICALS445 -
SANOFI5923 - -
THE MEDICINES UK2 - - -